Prime Medicine, Inc.
PRME- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001894562
No open-market purchases or sales by Prime Medicine, Inc. insiders were filed in the last 90 days; 187 institutions reported holding it in 13F filings for Q2 2026, worth $393.5M in total; ARK Invest is the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding Prime Medicine, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 0 | 66 | +66 |
| Shares | 0 | 41.3M | +41.3M |
| Value | $0 | $767.8M | +$767.8M |
New holders (66)
Institutions that held Prime Medicine, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (0)
Institutions that held Prime Medicine, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
None.